SunTrust Robinson Humphrey Maintains Buy on Biogen, Raises Price Target to $360

SunTrust Robinson Humphrey analyst Robyn Karnauskas maintains Biogen (NASDAQ:BIIB) with a Buy and raises the price target from $337 to $360.

Benzinga · 02/03/2020 12:33

SunTrust Robinson Humphrey analyst Robyn Karnauskas maintains Biogen (NASDAQ:BIIB) with a Buy and raises the price target from $337 to $360.